Silencing bcl-2 expression in epithelial cancer cells using "smart" particles

Area of Science:

• Biotechnology
• Polymer Chemistry
• Cancer Biology

Background:

• The anti-apoptotic Bcl-2 protein promotes cancer cell survival.
• Targeting Bcl-2 with short interfering RNA (siRNA) is a strategy to induce cancer cell death.
• Efficient delivery of siRNA into cancer cells remains a challenge.

Purpose of the Study:

• To develop and evaluate "smart" nanoparticles for delivering anti-Bcl-2 siRNA into cancer cells.
• To investigate the efficacy of these nanoparticles in suppressing Bcl-2 expression at both mRNA and protein levels.
• To assess the potential of this delivery system for cancer therapy.

Main Methods:

• Synthesis of a degradable, pH-sensitive, comb-like polymer [P(EAA-co-BMA)-b-PNASI-g-P(HMA-co-TMAEMA)].
• Complexation of anti-Bcl-2 siRNA with the polymer to form "smart" nanoparticles.
• Treatment of HeLa and UM-SCC-17B cancer cells with the anti-Bcl-2 nanoparticles.
• Quantification of Bcl-2 mRNA and protein levels using qRT-PCR and western blotting.

Main Results:

• The "smart" nanoparticles successfully delivered anti-Bcl-2 siRNA into the cytoplasm of HeLa and UM-SCC-17B cells.
• In HeLa cells, Bcl-2 mRNA levels were suppressed by 50%-60%, and protein levels by 79%-81%.
• In UM-SCC-17B cells, Bcl-2 mRNA levels were inhibited by 20%-40% over 48-96 hours, and protein levels by 30% at 72 hours.

Conclusions:

• The pH-sensitive comb-like polymer effectively complexes anti-Bcl-2 siRNA into "smart" nanoparticles.
• These nanoparticles facilitate endosomal escape and cytoplasmic delivery of siRNA cargo.
• The developed system demonstrates significant Bcl-2 knockdown at the mRNA and protein levels in cancer cells, indicating therapeutic potential.